healthcare.digital January 3, 2026
Executive Summary
The European healthcare technology and medical technology (MedTech) landscape entering 2026 stands at a profound inflection point, characterised by a transition from the speculative fragmentation of the early 2020s to a disciplined era of “industrial maturity.” Following a period of post-pandemic recalibration in 2024 and a stabilisation of valuations in 2025, the sector is now defined by a stark bifurcation in asset desirability.
Analysts have termed this phase the “Great Rationalisation,” where capital allocation is rigorously directed toward assets enabling the industrialisation of care—specifically through profitability, regulatory fortitude and operational leverage.
Notable valuation milestones underscoring this shift include Sword Health reaching a $4 Billion valuation on the back of its “AI Care” model, Oura achieving a staggering $11...
Today's Sponsors
Today's Sponsor